Pharmatica published its latest Insights examining new research into data integrity failures across pharmaceutical digital twins and continuous manufacturing.
Public source
Publisher name
Public post
Can you trust the data running your digital factory? Pharma manufacturing is becoming more connected… -Digital twins. -PAT. -IoT sensors. -AI. -Continuous manufacturing.…
Company
Pharmatica
Bridging the Clinical Truth Gap with Pharma Superintelligence
- Industry
- Pharmaceutical Manufacturing
- Location
- London, GB
- Company size
- 2–10 employees
About Pharmatica
Pharmatica: The Infrastructure of Truth Pharmatica is a dual-track intelligence powerhouse designed to close the "Truth Gap" between clinical intent and market reality. We operate at the intersection of strategic enablement and predictive analytics. Strategic Enablement: Connecting the Ecosystem We bridge the gap between elite Pharma Solution Providers and the industry’s high-command. By leveraging our Scientific Council, we bypass traditional gatekeeping and clinical inertia to connect innovative vendors directly with decision-makers. We provide the authority required for high-stakes partnerships. Predictive Intelligence: Seeing the Future Beyond connections, we provide the data required to dominate. Our AI-driven Neural Sieve transforms thousands of clinical interactions into actionable foresight: Sentinel: Real-time friction heatmaps identifying exactly where drug uptake is stalling today. Vanguard: Predictive forecasting that identifies market shifts 3–6 months before they appear in official sales data, with a verified 96% predictive accuracy. By correlating 14,000+ proprietary data points with global clinical sentiment, we give our partners the exclusive right to see the future of their therapeutic vertical. Pharmatica | Sentinel Insights. Vanguard Strategy. The Infrastructure of Truth.
See moreLatest activity
Latest activity from Pharmatica
9 signals
Research & Knowledge
Pharmatica published the PRIMA Trial, which showed more than double progression-free survival benefit in HRD-positive ovarian cancer for niraparib compared to placebo, with final overall survival numbers showing no significant difference after six years.
Research & Knowledge
Pharmatica published its latest Pharmatica Insights exploring what needs to happen next for digital health technologies in clinical drug development.
Presence & Recognition
Pharmatica featured Shubhangi Dua on Digital Pulse discussing fertility innovation, policy, AI, and workplace culture.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Orion GXP Consulting
Orion GXP Consulting published an article by Nick Corcoran exploring a practical use case for AI within pharmaceutical Quality Assurance using AI as a tool to support document review, challenge content, and identify potential gaps.
Research & Knowledge
Eli Lilly and Company
Eli Lilly and Company published a perspective article on Science Direct discussing the evolution of digital twins in biopharma manufacturing.
Research & Knowledge
The Association of the British Pharmaceutical Industry (ABPI)
The Association of the British Pharmaceutical Industry (ABPI) published the new UK Pharmaceutical Investment Competitiveness Report 2026, which reveals that since September 2025, £2 billion of new investment has been committed to the UK spanning AI-enabled drug discovery through to large-scale manufacturing.
Research & Knowledge
PSI CRO
PSI CRO published a white paper examining the operational reality of agentic AI in clinical development, including how AI is applied across feasibility, trial management, decision support, and execution oversight in complex global studies.
Research & Knowledge
Sterling Pharma Solutions